期刊文献+

高血压患者血尿酸水平与冠状动脉病变的关系 被引量:6

Relationship between uric acid and coronary lesion in patients with hypertension
原文传递
导出
摘要 目的探讨高血压患者血尿酸水平与冠状动脉病变程度的关系。方法51例非高血压患者及120例高血压患者行冠状动脉造影检查,冠脉狭窄≥50%者为冠心病组,冠脉造影未见异常者为冠脉正常组,再按照病变严重程度将高血压病合并冠心病患者分为单支、双支、3支病变3组,并检测血尿酸水平及血糖、血脂等生化指标。结果高血压患者冠脉造影阳性率为75.85%,高于非高血压组,两组比较差异有统计学意义(P〈0.01);高血压合并冠心病患者血尿酸水平高于单纯高血压患者,且升高程度与冠状动脉病变程度呈正相关(P〈0.01或P〈0.05)。结论高血压患者冠心病发病率高于非高血压患者,高血压合并冠心病患者血尿酸水平高于非冠心病患者,尿酸升高程度与冠脉病变程度一致。 Objective To study the relationship between serum uric acid and coronary lesion in patients with hypertension. Methods 171 patients undergoing diagnostic coronary angiography were di- vided into coronary heart disease(CHD) group( ≥50% diameter narrowing) and control group. 120 pa- tients with hypertension were further divided into four subgroups, the single-vessel group, the double-vessel group,the three-vessel group and non-CHD group. Serum uric acid,blood glucose,total cholesterol(TC) , triglycerides ( TG ), high-density lipoprotein ( HDL), low- density lipoprotein ( LDL ) were measured in all of the four groups of patients with hypertension. Results In patients with hypertension, the positive rate of diagnostic coronary angiography was 75.85% ;and in patients without hypertension ,the ratio of diagnostic coronary angiography was 70.69% ( P 〈 0.01 ). The levels of serum uric acid were higher in hypertension and CHD group than those of hypertension and non-CHD group( P 〈 0.01 ). And the higher levels of ser- um uric acid were corresponded with the more severity of coronary lesion in hypertension and CHD pa- tients. Conclusion There is higher morbidity and more complicated coronary lesion in hypertension than those of the non-hypertension. High level of uric acid may be indirectly assessing the coronary lesion.
出处 《临床内科杂志》 CAS 2012年第7期472-473,共2页 Journal of Clinical Internal Medicine
关键词 冠心病 高血压病 血尿酸 Coronary disease Hypertension Uric acid
  • 相关文献

参考文献8

  • 1张立晶,胡大一,杨进刚,许玉韵,李田昌,王国宏,史旭波,路亚枫.有心血管疾病危险因素人群中高尿酸血症的发生率及其相关因素[J].首都医科大学学报,2005,26(2):124-127. 被引量:56
  • 2Lu Z,Dong B,Wu H,et al. Serum uric acid level in primary hyperten- sions among Chinese nonagenarians/centenarians. J Ham hypenens, 2009,23 : 113-121.
  • 3Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis care Res (Hoboken) ,2010,62 : 170-180.
  • 4Verdecchia P,Schillaci G,Reboldi G, et al. Relation between serum u- ric acid and risk of cardiovascular disease in essential hypertension. The PTUMA study. Hypertension ,2009,36 : 1072-1078.
  • 5朱文玲.高尿酸血症合并心血管疾病诊治专家共识解读[J].中国心血管杂志,2010,15(6):412-414. 被引量:19
  • 6Faig DI, Mazzali M, Kang DH, et al. Serum uric acid:a risk a target for treatment? J Am Soc Nephrul,2006,17 (4Supply 2) :S69-73.
  • 7Hayden MR, Tyagi SC. Uric acid:a new look at an old risk markerfor cardio vascular disease,metabolic syndrome, and type 2 diabetes melli- tus :the urate redox shutter. Nutr Metab(lond) ,2004,1 : 10-15.
  • 8Khosla UM, Zhariko VS, Finch JL, et al. Hyperuricemia induces en-do- thelial dysfunction. Kidney Int,2005 ,67 :1739-1742.

二级参考文献16

  • 1张立晶,胡大一,杨进刚,许玉韵,李田昌,王国宏,史旭波,路亚枫.有心血管疾病危险因素人群中高尿酸血症的发生率及其相关因素[J].首都医科大学学报,2005,26(2):124-127. 被引量:56
  • 2Bickel C,Rupprecht HJ,Blankenberg S,et al.Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease.Am J Cardiol,2002,89:12-17.
  • 3Sakai H,Tsutamoto T,Tsutsui T,et al.Serum level of uric acid,partly secreted from the failing heart,is a prognostic marker in patients with congestive heart failure.Circ J,2006,70:1006-1011.
  • 4Perez-Ruiz F,Calabozo M,Femandez-Lopez MJ,et al.Treatment of chronic gout in patients with renal function impairment:an open,randomized,actively controlled study.J Clin Rheumatol,1999,5:249-255.
  • 5Kanbay M,Ozkara A,Selcoki Y,el al.Effect of treatment of hyperuricemia with allopurinol on blood pressure,creatinine clearence,and proteinuria in patients with normal renal functions.Int Urol Nephrol,2007,39:1227-1233.
  • 6Abbott R D, Brand F N, Kannel W B, et al. Gout and coronary disease: the framingham study. J Clin Epidemiol, 1988,41:237~242.
  • 7Johnson R J, Titte S, Cade J R, et al. Uric acid, evolution and primitive cultures. Semin Nephrol, 2005,25:3~8.
  • 8Levine W, Dyer A R, Shekelle R B, et al. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the chicago heart association detection project in industory. J Clin Epidemiol, 1989,42:257~267.
  • 9Jackson L, Taylor R, Faaiuso S. Hyperuricemia and gout in western Samoans. J Chronic Dis, 1981,34:65~75.
  • 10Yamashita S, Matsuzawa Y, Tokunaga K, et al. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes, 1986,10:255~264.

共引文献71

同被引文献51

  • 1周宇明.浅谈血尿酸水平与高血压疾病发生和发展的关系[J].当代医药论丛,2014,12(4):173-174. 被引量:2
  • 2黄浙勇,江时森.右冠状动脉病变对左室功能的影响[J].心血管康复医学杂志,2006,15(1):99-102. 被引量:1
  • 3颜秉菊,蔡久英.高尿酸血症与冠心病及其危险因素的研究进展[J].医学综述,2006,12(14):854-856. 被引量:24
  • 4Wong BW,Meredith A,Lin D,et al.The biological role of inflammation in atherosclerosis[J].Can J Cardiol,2012,28 (6):631-641.
  • 5Kubik M,Chudek J,Adamczak M,et al.Telmisartan improves cardiometabolic profile in obese patients with arterial hypertension[J].Kidney Blood Press Res,2012,35(4):281-289.
  • 6Khan BV.The effect of amlodipine besylate,losartan potassium,olmesartan medoxomil,and other antihypertensives on central aortic blood pressure and biomarkers of vascular function[J].Ther Adv Cardiovasc Dis,2011,5 (5):241-273.
  • 7王纪佐,李新.青年人卒中[M].现代脑血管病学.北京:人民军医出版社,2003:244.
  • 8Fang J, Aldermn MI-I. ScrumUric acid and cardiovascular mortalitythe NHANESI epidemiologicfollow-upstudy, 1971 - 1992. National- HealthandNutrition Examination Survey [ J ]. JAMA ,2000,283 ( 18 ) : 2404 - 2410.
  • 9Strasak SH,Ruttmann E,Brant L,et al. serum uric acid and risk of cardiovascular mortality : a prospectivelong-term study of 83 683Austrian men[J]. Clin Chem,2008,54(2) :273 -284.
  • 10Park SH, Shin WY, leeEY, et al. Thelmpact of hyperuficemia nin- hospitalmortality andincidence of acute kidneyingury in patientsund Ergoing percutaneous coronary intervention [ J ]. CircJ ,2011,75 ( 3 ) : 692 - 697.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部